BRD4 regulates key transcription factors that drive epithelial–mesenchymal transition in castration-resistant prostate cancer

被引：0
|
作者：
Jordan S. Shafran
Naser Jafari
Allison N. Casey
Balázs Győrffy
Gerald V. Denis
机构：
[1] Boston University-Boston Medical Center Cancer Center,Department of Molecular and Translational Medicine
[2] Boston University School of Medicine,Department of Biomedical Engineering
[3] Boston University,Department of Bioinformatics and 2nd Department of Pediatrics
[4] Semmelweis University,TTK Lendület Cancer Biomarker Research Group
[5] Institute of Enzymology,Department of Pharmacology and Experimental Therapeutics
[6] Boston University School of Medicine,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：268 / 277
页数：9
相关论文
共 50 条
  • [1] BRD4 regulates key transcription factors that drive epithelial-mesenchymal transition in castration-resistant prostate cancer
    Shafran, Jordan S.
    Jafari, Naser
    Casey, Allison N.
    Gyorffy, Balazs
    Denis, Gerald, V
    PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (01) : 268 - 277
  • [2] BRD4 Regulates Metastatic Potential of Castration-Resistant Prostate Cancer through AHNAK
    Shafran, Jordan S.
    Andrieu, Guillaume P.
    Gyorffy, Balazs
    Denis, Gerald V.
    MOLECULAR CANCER RESEARCH, 2019, 17 (08) : 1627 - 1638
  • [3] Targeting CDCP1 gene transcription coactivated by BRD4 and CBP/p300 in castration-resistant prostate cancer
    Ji, Donglei
    Shang, Guanglei
    Wei, Enwei
    Jia, Yanjie
    Wang, Chunyu
    Zhang, Qiang
    Zeng, Lei
    ONCOGENE, 2022, 41 (23) : 3251 - 3262
  • [4] Targeting CDCP1 gene transcription coactivated by BRD4 and CBP/p300 in castration-resistant prostate cancer
    Donglei Ji
    Guanglei Shang
    Enwei Wei
    Yanjie Jia
    Chunyu Wang
    Qiang Zhang
    Lei Zeng
    Oncogene, 2022, 41 : 3251 - 3262
  • [5] Reversion of epithelial-mesenchymal transition (EMT) as a mechanism of action of cabazitazel in castration-resistant prostate cancer
    Jimenez, N.
    Marin-Aguilera, M.
    Reig, O.
    Fernandez, P. L.
    Garcia-Recio, S.
    Pereira, M. V.
    Prat, A.
    Mellado Gonzalez, B.
    ANNALS OF ONCOLOGY, 2017, 28
  • [6] A Novel Mechanism to Drive Castration-Resistant Prostate Cancer
    Kaochar, Salma
    Mitsiades, Nicholas
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2018, 29 (06): : 366 - 368
  • [7] Different degree of epithelial-mesenchymal transition phenotype in docetaxel and cabazitaxel castration-resistant prostate cancer cells
    Jimenez, N.
    Marin-Aguilera, M.
    Reig, O.
    Nadal, L.
    Garcia-Recio, S.
    Pereira, M. V.
    Prat, A.
    Mellado, B.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S75 - S76
  • [8] LSD1 activates oncogenic super-enhancers in castration-resistant prostate cancer by forming nuclear condensates with BRD4
    Liu, Mingyu
    Li, Muqing
    Han, Dong
    Wang, Zifeng
    Han, Wanting
    He, Housheng Hansen
    Gao, Shuai
    Cai, Changmeng
    CANCER RESEARCH, 2023, 83 (07)
  • [9] CYP19A1 is downregulated by BRD4 and suppresses castration-resistant prostate cancer cell invasion and proliferation by decreasing AR expression
    Chen, Xi
    Li, Haopeng
    Xu, Chengdang
    Wang, Xin'an
    Wu, Gang
    Li, Chao
    Wu, Denglong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (09): : 4003 - 4020
  • [10] HDAC inhibition impedes epithelial–mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer
    M Ruscetti
    E L Dadashian
    W Guo
    B Quach
    D J Mulholland
    J W Park
    L M Tran
    N Kobayashi
    D Bianchi-Frias
    Y Xing
    P S Nelson
    H Wu
    Oncogene, 2016, 35 : 3781 - 3795
12345